It’s me! (Again 🙄) Lucas Hill, PharmD, FCCP and our whole #TxSUS2023 team welcome you to our upcoming meeting. Please join this amazing community gathering. Very excited that other NIDAnews researchers will be joining us to share their science.

Cancer, more than a “COVID-19 co-morbidity” [Mar 13, 2023] Chinmay Jani et al. Frontiers - Oncology frontiersin.org/articles/10.33… #COVID19nCancer #2019nCoV #COVID19

Convalescent Plasma and Survival in Hematologic Malignancy and COVID-19 [Jun 17, 2021] Mike Thompson, MD, PhD, FASCO & Jeff Henderson MDPhD et al. Jack Senefeld Dimpy Shah MD, PhD @hemoncwarner COVID-19 and Cancer Consortium (CCC19) Registry - JAMA Oncology ow.ly/SJJu50FcCmD #COVID19CP #CCC19 #COVID19nCancer #COVID19 #IDonc

Primary data vs click bait headers --> A meta-analysis of the associations b/w insufficient sleep duration and antibody response to vaccination [Mar 13, 2023] Spiegel et al. Current Biology cell.com/current-biolog… #COVID19Vaccine Interesting, but look at effect size & CI

Mobile health component of #NIHRECOVER is launching, with Fitbits available for many participants who don't have them. Also, #MECFS community, will allow for daily symptom tracking - e.g. of PEM. webmd.com/covid/news/202… from WebMD;

🎙️[tap,tap] Is this thing on? I was SO LUCKY to work on 1⃣7⃣ #ASCO23 abstracts focusing on access, affordability, & equity in oncology. 3⃣orals: Dr Bismarck Odei MD on #burnout Dr Kanan Shah, MD on equity for the unhomed (🏆MERIT AWARD) Dr Emily MacDuffie on #Fertility & #GenderEquity (1/🧵)

👉👉👉Our group’s new paper led by Dr Phil Thompson & Dr ⁦Bill Wierda, MD, PhD⁩ 📣 VEN consolidation in high-risk CLL treated w/IBR for ≥1 year 👉achieves a high rate of undetectable MRD⁩ | ⁦Nitin Jain⁩ ⁦Tapan Kadia⁩⁩ ⁦⁩⁦Sa A Wang, MD⁩ nature.com/articles/s4137…

With pressure on Congress to address the debt ceiling, lawmakers are considering spending cuts to cancer research funding. 📣 Urge lawmakers to prioritize continued progress to conquer cancer by ⬆️ federal research funding in FY24: fal.cn/3xXTY #ASCOAdvocacySummit

Texas tops the list of worst states for mental health care forbes.com/advisor/health…

Legislation aimed at improving health outcomes for Texans is Headed to the Governor’s Desk. Today, the Texas House of Representatives passed Senate Bill 989 to increase access to biomarker testing, which can help determine the best treatment plan for each patient. The American

1st #NIHRECOVER adult cohort results are out today in JAMA, proposing an expanded working definition of #LongCovid (aka post-acute sequelae of SARS-CoV-2 [PASC]). Led by tanayott (tony) thaweethai, this is a dense paper with a ton of results. Buckle up! 🧵 jamanetwork.com/journals/jama/…

Well nuts the link is broken. Trying again opa.uthscsa.edu/position-listi…

#COVID19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study [Feb 27, 2023] Joaquín Martínez-López et al. Cancers MDPI mdpi.com/2072-6694/15/5… #COVID19nCancer #lymsm #leusm #mmsm #mpnsm

Register for the San Antonio Liver Cancer Symposium Oct 20-21. We are honored to have world-renowned experts speak and attend! @UTHealthSAMDA UT Health San Antonio Research University Health @AlexParikhMD Danielle Fritze Colin Court Sepideh Gholami, MD, MAS, FACS, FSSO Jean-Nicolas Vauthey MD @TimGreten Xin Wei Wang Anuradha Budhu LCP

Blue Faery Andrea Wilson Woods Neil Newman Emma B. Holliday MD COLONTOWN Colon Cancer Foundation Alicia Logue Dimpy Shah MD, PhD Anna Capasso

COVID‐19 vaccine effectiveness in patients with hematologic malignancy [May 18, 2022] Dimpy Shah MD, PhD Pankil Mike Thompson, MD, PhD, FASCO Transplant ID onlinelibrary.wiley.com/doi/10.1111/ti… #COVID19Vaccine #COVID19nCancer #bmtsm #leusm #lymsm #mmsm #mpnsm #IDonc

1/ We are thrilled to share our paper "Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19" published in JAMA Oncology with COVID-19 and Cancer Consortium (CCC19) Registry jamanetwork.com/journals/jamao…

5/ In the model for combined ATE/VTE, Black patients compared with White patients) at a significantly high risk

Huge thanks to Rachel Rosovsky and Dimpy Shah MD, PhD as well as #ChihYuanHsu and #JeremyWarner and of course each and every investigator who helped with data collection. Also appreciate the funding support from @NATFthrombosis to conduct the study!

Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patients [Sep 6, 2023] Ben Teh et al. The Lancet Infectious Diseases doi.org/10.1016/S1473-… #IDonc #leusm #lymsm #mmsm #mpnsm #caxtx